NDC 51672-1402-08 - Calcipotriene and Betamethasone Dipropionate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51672-1402
- Requested NDC
- 51672-1402-08
- Package NDCs from labels
- 51672-1402-4, 51672-1402-8, 51672-1402-08
- Manufacturer
- Sun Pharmaceutical Industries, Inc. | Sun Pharma Canada Inc.
- Effective date
- 2025-07-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| MINERAL OIL - Sun Pharmaceutical Industries, Inc. | Sun Pharma Canada Inc. | Sun Pharmaceutical Industries, Inc. | Sun Pharma Canada Inc. | 2025-07-01 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51672-1402-4 | Calcipotriene and Betamethasone Dipropionate | 60 g in 1 BOTTLE | SUSPENSION | 60 | 2 | |
| 51672-1402-4 | Calcipotriene and Betamethasone Dipropionate | 1 in 1 CARTON | SUSPENSION | 1 | 2 | |
| 51672-1402-8 | Calcipotriene and Betamethasone Dipropionate | 60 g in 1 BOTTLE | SUSPENSION | 60 | 2 | |
| 51672-1402-8 | Calcipotriene and Betamethasone Dipropionate | 2 in 1 CARTON | SUSPENSION | 2 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51672-1402 | CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE SUSPENSION [TARO PHARMACEUTICALS U.S.A., INC.] | 1 | Current NDC, Legacy NDC, 4 package rows | 20200904_1d0ab2e6-1ab1-4d3e-ad55-7fa26446f191.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Mineral Oil | MINERAL OIL | Perrigo Direct, Inc | f1656280-fad9-4922-9d5c-be774a8b1422 | 2026-02-19 | Warnings, Adverse reactions | T5L8T28FGP |
| Mineral Oil | MINERAL OIL | Meijer, Inc. | 652d1da9-a71f-4113-9ef3-da0916724625 | 2026-02-19 | Warnings, Adverse reactions | T5L8T28FGP |
| Mineral Oil | MINERAL OIL | Target Corporation | 526508f0-e908-4e3d-88f5-404a95f6de76 | 2026-02-18 | Warnings, Adverse reactions | T5L8T28FGP |
| Mineral Oil | MINERAL OIL | United Natural Foods, Inc. dba UNFI | cb7bc571-295f-47c2-ae93-18cba194752c | 2026-02-17 | Warnings, Adverse reactions | T5L8T28FGP |
| Mineral Oil | MINERAL OIL | Strategic Sourcing Services LLC | e4965086-dcc0-4b34-bb30-81facf7139f3 | 2026-02-17 | Warnings, Adverse reactions | T5L8T28FGP |
| Mineral Oil | MINERAL OIL | Topco Associates LLC | e9b1fd61-c229-4529-82c2-d6ac5b076082 | 2026-02-13 | Warnings | T5L8T28FGP |
| Mineral Oil | MINERAL OIL | Walgreen Co. | 822fd02a-92b0-4010-8bfb-737dba331d54 | 2026-02-12 | Warnings, Adverse reactions | T5L8T28FGP |
| Mineral Oil | MINERAL OIL | Retail Business Services, LLC | b0abcdf9-c226-424f-8970-c2135708c6c8 | 2026-02-06 | Warnings, Adverse reactions | T5L8T28FGP |
| Betamethasone Dipropionate | BETAMETHASONE DIPROPIONATE | A-S Medication Solutions | abd5a08c-4bb7-46c9-9e2e-0a89c43d46c8 | 2026-02-06 | Warnings, Adverse reactions | 826Y60901U |
| Signature Care Hemorrhoidal | MINERAL OIL, PETROLATUM, AND PHENYLEPHRINE HCI | Better Living Brands, LLC | 3c8b43f3-6e1e-499e-ba71-ffdf836f6743 | 2026-02-05 | Warnings | T5L8T28FGP |
| 0.25 % PHENYLEPHRINE HCl HEMORRHOIDAL | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HYDROCHLORIDE | Nantong Health & Beyond Hygienic Products Inc. | 1cada0ae-3f0f-441c-a633-faa0a3009d2b | 2026-02-05 | Warnings | T5L8T28FGP |
| Harris Teeter | MINERAL | Harris Teeter | 401e3a7e-54be-47cc-88c3-a343f5cbbd10 | 2026-02-04 | Warnings, Adverse reactions | T5L8T28FGP |
| Hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCL | Sportpharm LLC | 88e3624d-b8bb-4e65-9250-4c51d2bbed16 | 2026-02-03 | Warnings | T5L8T28FGP |
| Betamethasone Dipropionate | BETAMETHASONE DIPROPIONATE | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC | 4f411e41-00dc-47cf-8517-3ff5876e1bf5 | 2026-01-30 | Warnings, Adverse reactions | 826Y60901U |
| Betamethasone Dipropionate | BETAMETHASONE DIPROPIONATE | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC | 853399f8-95a7-41f3-80e7-7ed8e3ff1a5e | 2026-01-30 | Warnings, Adverse reactions | 826Y60901U |
| Mineral Oil | MINERAL OIL | CARDINAL HEALTH 110, LLC. DBA LEADER | 803f444f-d136-4f06-9842-24a71a3d7d6b | 2026-01-29 | Warnings, Adverse reactions | T5L8T28FGP |
| careone hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCL | American Sales Company | 46794d2e-8fe6-490d-9cfa-ba9b6c209ad6 | 2026-01-29 | Warnings | T5L8T28FGP |
| Calcipotriene | CALCIPOTRIENE | Glenmark Pharmaceuticals Inc., USA | 1bc020e0-b5ae-4cda-aa5b-87fa0452a6bc | 2026-01-23 | Warnings, Adverse reactions | 143NQ3779B |
| foster and thrive hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCL | Strategic Sourcing Services LLC | 9da843f2-e88c-432e-b091-a6acf81d856b | 2026-01-22 | Warnings | T5L8T28FGP |
| Betamethasone Dipropionate USP, 0.05% | BETAMETHASONE DIPROPIONATE USP, 0.05% | TruPharma LLC | fc34987a-e803-4ac8-8a1e-9bdadd3f8b56 | 2026-01-18 | Adverse reactions | 826Y60901U |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.